Journal of Hepatology
Volume 46, Issue 4 , Pages 557-564 , April 2007

Acute liver failure: Bridging to transplant or recovery– are we there yet?

References 

  1. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol. 2004;40:192–197
  2. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–954
  3. Barber K, Blackwell J, Collett D, Neuberger J. Life expectancy of adult liver allograft recipients in the UK. Gut 2006, (Epub ahead of print).
  4. Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl. 2005;11:1073–1079
  5. Sen S, Williams R. New liver support devices in acute liver failure: a critical evaluation. Semin Liver Dis. 2003;23:283–294
  6. Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut. 2004;53:890–898
  7. Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices. Hepatology. 2001;34:447–455
  8. Ben-Haim M, Emre S, Fishbein TM, Sheiner PA, Bodian CA, Kim-Schluger L, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient’s disease. Liver Transpl. 2001;7:948–953
  9. Rozga J, Williams F, Ro MS, Neuzil DF, Giorgio TD, Backfisch G, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology. 1993;17:258–265
  10. Flendrig LM, la Soe JW, Jorning GG, Steenbeek A, Karlsen OT, Bovee WM, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol. 1997;26:1379–1392
  11. Nyberg SL, Hibbs JR, Hardin JA, Germer JJ, Persing DH. Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. Transplantation. 1999;67:1251–1255
  12. Sussman NL, Chong MG, Koussayer T, He DE, Shang TA, Whisennand HH, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology. 1992;16:60–65
  13. Sauer IM, Gerlach JC. Modular extracorporeal liver support. Artif Organs. 2002;26:703–706
  14. Barshes NR, Gay AN, Williams B, Patel AJ, Awad SS. Support for the acutely failing liver: a comprehensive review of historic and contemporary strategies. J Am Coll Surg. 2005;201:458–476
  15. Demetriou AA, Brown RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239:660–667
  16. Samuel D, Ichai P, Feray C, Saliba F, Azoulay D, Arulnaden JL, et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation. 2002;73:257–264
  17. Stockmann HB, Hiemstra CA, Marquet RL, IJzermans JN. Extracorporeal perfusion for the treatment of acute liver failure. Ann Surg. 2000;231:460–470
  18. Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs. 1996;19:677–691
  19. Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther. 2006;23:351–363
  20. Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl. 2004;10:1099–1106
  21. Kjaergard LL, Liu J, ls-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA. 2003;289:217–222
  22. Stange J. Meta-analysis in albumin dialysis: are we really ready for it?. Liver Transpl. 2004;10:1107–1108
  23. Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, et al. One hundred sixteen cases of acute liver failure treated with MARS. Transplant Proc. 2005;37:2557–2559
  24. Camus C, Lavoue S, Gacouin A, Le TY, Lorho R, Boudjema K, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med. 2006;32:1817–1825
  25. Koivusalo AM, Vakkuri A, Hockerstedt K, Isoniemi H. Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency. Transplant Proc. 2005;37:3315–3317
  26. Lee KH, Lee MK, Sutedja DS, Lim SG. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Liver Int. 2005;25:973–977
  27. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry. Liver. 2002;22:20–25
  28. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, et al. Prometheus – a new extracorporeal system for the treatment of liver failure. J Hepatol. 2003;39:984–990
  29. Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs. 2006;30:276–284
  30. Junge G, Schewior LV, Kohler S, Pratschke J, Neumann UP, Nuessler N, et al. Acute liver failure: Fractionated PlasmaSeparation/Adsorption (FPSA) and High-Flux Hemodialysis (HD) for bridging therapy to liver transplantation. Hepatology. 2006;44:366A
  31. Iwai H, Nagaki M, Naito T, Ishiki Y, Murakami N, Sugihara J, et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med. 1998;26:873–876
  32. Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol. 2001;96:1217–1223
  33. Jalan R, Williams R. Bio-artificial liver support for acute liver failure: should we be using it to treat patients?. Transplantation. 2002;73:165–166
  34. Horslen SP, Fox IJ. Hepatocyte transplantation. Transplantation. 2004;77:1481–1486
  35. Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation. 1997;63:559–569
  36. Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, Stephens J, et al. Hepatocyte transplantation in acute liver failure. Liver Transpl. 2000;6:32–40
  37. Nussler A, Konig S, Ott M, Sokal E, Christ B, Thasler W, et al. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol. 2006;45:144–159
  38. Rust C, Gores GJ. Hepatocyte transplantation in acute liver failure: a new therapeutic option for the next millennium?. Liver Transpl. 2000;6:41–43
  39. Baccarani U, Sanna A, Cariani A, Sainz-Barriga M, Adani GL, Zambito AM, et al. Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience. Liver Transpl. 2003;9:506–512
  40. Nowak G, Ericzon BG, Nava S, Jaksch M, Westgren M, Sumitran-Holgersson S. Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo. Gut. 2005;54:972–979
  41. Suzuki A, Nakauchi H, Taniguchi H. In vitro production of functionally mature hepatocytes from prospectively isolated hepatic stem cells. Cell Transplant. 2003;12:469–473
  42. Stieger B, Peters R, Sidler MA, Meier PJ. Hepatocyte transplantation: potential of hepatocyte progenitor cells and bone marrow derived stem cells. Swiss Med Wkly. 2006;136:552–556
  43. Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayr R. Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg. 1993;218:3–9
  44. Nardo B, Puviani L, Caraceni P, Montalti R, Pacile V, Bertelli R, et al. Technical aspects of portal vein arterialization for acute liver failure: from rat lab to man. Transplant Proc. 2006;38:1195–1197
  45. Schleimer K, Stippel DL, Kasper HU, Tawadros S, Suer C, Schomacker K, et al. Auxiliary liver transplantation with flow-regulated portal vein arterialization offers a successful therapeutic option in acute hepatic failure – investigations in heterotopic auxiliary rat liver transplantation. Transpl Int. 2006;19:581–588
  46. Nishio R, Nakayama M, Ikekita M, Watanabe Y. Auxiliary liver organ formation by implantation of spleen-encapsulated hepatocytes. Tissue Eng. 2006;12:2565–2572
  47. Patzer JF, Mazariegos GV, Lopez R. Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System. J Am Coll Surg. 2002;195:299–310
  48. Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 1996;24:1446–1451
  49. van de Kerkhove MP, Di FE, Scuderi V, Mancini A, Belli A, Bracco A, et al. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs. 2002;25:950–959
  50. Sauer IM, Zeilinger K, Obermayer N, Pless G, Grunwald A, Pascher A, et al. Primary human liver cells as source for modular extracorporeal liver support – a preliminary report. Int J Artif Organs. 2002;25:1001–1005

PII: S0168-8278(07)00051-7

doi: 10.1016/j.jhep.2007.01.010

Journal of Hepatology
Volume 46, Issue 4 , Pages 557-564 , April 2007

Article Tools